2014
DOI: 10.7150/thno.7193
|View full text |Cite
|
Sign up to set email alerts
|

Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?

Abstract: Nano-sized therapeutic agents have several advantages over low molecular weight agents such as a larger loading capacity, the ability to protect the payload until delivery, more specific targeting due to multivalency and the opportunity for controlled/sustained release. However, the delivery of nano-sized agents into cancer tissue is problematic because it mostly relies on the enhanced permeability and retention (EPR) effect that depends on the leaky nature of the tumor vasculature and the prolonged circulatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

11
572
0
2

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 855 publications
(599 citation statements)
references
References 70 publications
(70 reference statements)
11
572
0
2
Order By: Relevance
“…In addition, PCL NPs are larger than PLA NPs, which is in a good agreement with the dynamic light scattering data for the two polymers. When administrated intravenously, NPs should be sufficiently small (100-300 nm) to passively cross the tumor endothelial barrier and then retain in the tumor bed for prolonged time due to 22 reduced lymphatic drainage, which is known as the enhanced permeability and retention effect (Kobayashi et al, 2014). Particles larger than 1 µm are not convenient for intravascular delivery of drugs, since they can readily be opsonized with a possibility of capillary occlusion, while NPs smaller than 5 nm can be cleared rapidly from the blood via extravasation or renal clearance (Elsabahy and Wooley, 2012).…”
Section: Microscopic Images Of Npsmentioning
confidence: 99%
“…In addition, PCL NPs are larger than PLA NPs, which is in a good agreement with the dynamic light scattering data for the two polymers. When administrated intravenously, NPs should be sufficiently small (100-300 nm) to passively cross the tumor endothelial barrier and then retain in the tumor bed for prolonged time due to 22 reduced lymphatic drainage, which is known as the enhanced permeability and retention effect (Kobayashi et al, 2014). Particles larger than 1 µm are not convenient for intravascular delivery of drugs, since they can readily be opsonized with a possibility of capillary occlusion, while NPs smaller than 5 nm can be cleared rapidly from the blood via extravasation or renal clearance (Elsabahy and Wooley, 2012).…”
Section: Microscopic Images Of Npsmentioning
confidence: 99%
“…However, optimized size of liposomal formulation is a critical aspect in order to develop efficient therapeutics against glioma. It has been reported in the literature that a nanosize (5200 nm) drug carrier can exploit the advantages of leaky vasculature associated with primary brain cancer for transport of therapeutic payload within the tumor easily through a common mechanism known as enhanced permeability and retention effect (EPR) (Kobayashi et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…33,34 The nontoxic and hydrophilic metal NPs could improve solubility issues and enhance tumor targeting due to the higher penetration and retention effects. 33,34 Hence, we also investigated and report herein the photooxidative capability of bio-SPIONs relative to HeLa cells.…”
Section: Introductionmentioning
confidence: 99%